Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?
about
Effects of tobacco smoking and nicotine on cancer treatment.Simple methodology for the therapeutic drug monitoring of the tyrosine kinase inhibitors dasatinib and imatinib.Moving on up: Second-Line Agents as Initial Treatment for Newly-Diagnosed Patients with Chronic Phase CML.Educating our students about pharmaceutical care for those living with cancer.Comparative pharmacokinetic evaluation and bioequivalence study of three different formulations of Imatinib Mesylate in CML patientsDrug-drug interactions with imatinib: An observational study.The paradigm of personalized therapy in oncology.Adherence to imatinib therapy in gastrointestinal stromal tumors and chronic myeloid leukemia.Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy.Improving adherence to oral cancer therapy in clinical practice.Therapeutic drug monitoring of targeted anticancer therapy.A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor.Synthesis and Evaluation of New Benzodioxole- Based Thiosemicarbazone Derivatives as Potential Antitumor Agents.Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers.Therapeutic drug monitoring of imatinibClinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.Imatinib Pharmacokinetics in a Large Observational Cohort of Gastrointestinal Stromal Tumour Patients.Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs.Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice
P2860
Q34303604-C2D29211-1796-4D5E-8412-CF910BCAD1B4Q34377463-A243D95B-6DAF-4CEF-99FE-8CB8DA180A3DQ35117747-A8208850-7FD3-462A-92F4-8FB306A27CEAQ36251596-3CAC8F4C-6127-4430-96E4-0626AB3CAAD6Q36566250-108ED2B8-F722-4D0E-9484-CFF6061F68C6Q37328934-9CC0ECBB-F69A-4C5F-AA83-C64796BD3FB3Q37954671-102D84D6-74DD-4E04-BA68-E0AC85D53022Q38109527-965D177E-D66D-42C2-BA05-1FAC6EE35A24Q38112821-70618A67-380A-4A0C-8C55-77772C5F61BFQ38216035-839772C3-6C1F-48FD-86FE-A902F5A757E4Q38579278-9D69F7C9-1AB5-4672-A5AC-81290C94B201Q38729029-62C1E1B4-4FA9-463A-89E1-ECA3329BC3BDQ38729281-174CA5E0-3505-4DC8-9B42-6937EEB3B0FCQ39345492-18ECAC88-635C-4301-B7EA-A5E1EF326A9DQ42269517-DA007E04-43C2-4BB2-A841-7F262BEAB463Q43841175-D9FF8D2D-0FEB-424A-9049-9A88A6663C2AQ48152547-3E5378CC-C727-477C-9551-A394B455DC86Q48248167-967F24FF-A920-4AE9-BE24-E6EB4EDE9FCEQ56979972-C7B08B4B-5E75-4574-B39C-971B1FC82AA8
P2860
Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Correlations between imatinib ...... for drug blood level testing?
@en
Correlations between imatinib ...... for drug blood level testing?
@nl
type
label
Correlations between imatinib ...... for drug blood level testing?
@en
Correlations between imatinib ...... for drug blood level testing?
@nl
prefLabel
Correlations between imatinib ...... for drug blood level testing?
@en
Correlations between imatinib ...... for drug blood level testing?
@nl
P2860
P1476
Correlations between imatinib ...... for drug blood level testing?
@en
P2860
P304
P356
10.1016/J.CTRV.2010.10.001
P577
2010-11-24T00:00:00Z